InvestorsHub Logo
icon url

ATLnsider

11/27/22 2:00 AM

#539302 RE: Larppis #539299

Thank you Larppis, for confirming that Dr. Liau did indeed say that UCLA is collaborating with BMS on the combo trial with: DCVax-L + PD-1 inhibitor + CSF-1 receptor inhibitor.

I do think it is possible that UCLA is collaborating with both BMS (BMY) & Merck (MRK).
Bullish
Bullish